Enucleation: Is wrapping the implant necessary for optimal motility?

被引:19
作者
Long, JA [1 ]
Tann, TA [1 ]
Bearden, WH [1 ]
Callahan, MA [1 ]
机构
[1] Univ Alabama, Dept Ophthalmol, Birmingham, AL 35294 USA
关键词
D O I
10.1097/01.IOP.0000066647.77902.0B
中图分类号
R77 [眼科学];
学科分类号
100212 [眼科学];
摘要
Purpose. To compare the mobility of wrapped and unwrapped hydroxyapatite orbital implants after enucleation. Methods: Fifteen consecutive adult patients underwent enucleation with hydroxyapatite implant placement. These patients randomly received either a wrapped or unwrapped implant. A masked observer measured the motility of implants at 6 weeks after implantation. The conjunctiva was marked and measured with a ruler. These measurements were used to compare the motility of the wrapped versus unwrapped implant. Results: The mean elevation for the wrapped group (n = 7) was 4 mm and for the unwrapped group (n = 8) was 3.9 mm. Depression was 4.1 mm for the wrapped group and 3.6 mm for the unwrapped group. Medial excursions were 5.3 for the wrapped group and 5.0 mm for the unwrapped group. Lateral excursions were 3.7 mm for the wrapped group and 3.5 mm for the unwrapped group. A repeated-measures analysis of variance was performed, and no statistically significant difference was found between the two groups. Conclusions: We conclude that placement of unwrapped hydroxyapatite implants after enucleation provides essentially the same motility as wrapped implants. This technique also saves time and money and eliminates the possibility of infectious disease transmission from donor wrapping materials.
引用
收藏
页码:194 / 197
页数:4
相关论文
共 22 条
[1]
TISSUE BREAKDOWN AND EXPOSURE ASSOCIATED WITH ORBITAL HYDROXYAPATITE IMPLANTS [J].
BUETTNER, H ;
BARTLEY, GB .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1992, 113 (06) :669-673
[2]
CANTRILL HL, 1988, OPHTHALMOLOGY, V95, P1458
[3]
Comparative motility of hydroxyapatite and alloplastic enucleation implants [J].
Custer, PL ;
Trinkaus, KM ;
Fornoff, J .
OPHTHALMOLOGY, 1999, 106 (03) :513-516
[4]
DEMER JL, 1995, INVEST OPHTH VIS SCI, V36, P1125
[5]
USE OF THE HYDROXYAPATITE OCULAR IMPLANT IN THE PEDIATRIC POPULATION [J].
DEPOTTER, P ;
SHIELDS, CL ;
SHIELDS, JA ;
SINGH, AD .
ARCHIVES OF OPHTHALMOLOGY, 1994, 112 (02) :208-212
[6]
A comparison of rates of fibrovascular ingrowth in wrapped versus unwrapped hydroxyapatite spheres in a rabbit model [J].
Gayre, GS ;
Lipham, W ;
Dutton, JJ .
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2002, 18 (04) :275-280
[7]
GOUGELMANN HP, 1970, OCULOPLASTIC SURGERY, P689
[8]
Prevention and management of complications associated with the hydroxyapatite implant [J].
Kaltreider, SA ;
Newman, SA .
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 1996, 12 (01) :18-31
[9]
KOOMEEF L, 1977, ARCH OPHTHALMOL-CHIC, V95, P1269
[10]
KOORNEEF L, 1979, OPHTHALMOLOGY, V86, P876